Tumour specific research: gastrointestinal
Clinical development of catumaxomab (Removab) in malignant ascites
Capecitabine/oxaliplatin vs 5FU/oxaliplatin combination chemotherapy in advanced colorectal cancer (aCRC): the MRC COIN trial experience
Mismatch repair status in stage II colorectal cancer : Substantially reduced recurrence rate in mismatch repair deficient tumours supports routine testing
A novel colorectal cancer susceptibility SNP in the EIF3H promoter influences patient survival and response to treatment
Integrated analysis of genome-wide copy number and expression changes reveals novel genes in oesophageal adenocarcinoma
Comparison of Loss of MLH1 and MSH2 Expression Between Oesophageal Cancer and Other Sporadic Cancers of the Gastrointestinal Tract – Relationship With Survival in 1027 Cases
Porfimer sodium photodynamic therapy (PDT) plus stenting versus stenting alone in patients (pts) with advanced or metastatic cholangiocarcinomas and other biliary tract tumours (BTC): a randomised phase lll study (Photostent-02)
Thirty-day post-operative mortality after colorectal cancer surgery in England
Test
